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Summary-The effect of the selective p-opioid agonist o-Ala2-Me-Phe4-Gly-ol'-enkephalin (DAGO), 
injected into the medial preoptic nucleus of hypothalamus, on cardiac output and regional blood flow 
was studied in the conscious rat and the effect of DAGO on renal sympathetic nerve activity and renal 
blood flow was studied in anesthetized rats. In conscious rats, injections of DAGO (1 or 10 nmol) into 
the preoptic nucleus increased the blood pressure in a dose-related manner. The maximum rises of mean 
arterial pressure and pulse pressure after the larger dose were +23 ± 5 mmHg (mean ±SEM, P < 0.01) 
and + 17 ± 3 mmHg(P < 0.01), respectively. A small dose (0.1 nmol) increased heart rate ( +47 ± 13 bpm, 
P < 0.05); thc 1 nmol dosc produced bradycardia (- 39 ± 11 bpm, P < 0.05), while the 10 nmol dose 
initially decreased heart rate ( -68 ± 15 bpm (P < 0.01) and then gradually increased heart rate to a 
maximum of + 74 ± 13 bpm, (P < 0.0 1). A long-lasting increase in cardiac outpul was also elicited by 
DAGO, with maximum changes after 1 and 10 nmol of + 14 ± 6% and +22 ± 7% (P < 0.01), 
respectively. B1ood flow in the hindquarters increascd after DAGO but the mesenteric and renal blood 
ftow decreased in a dose-related manner. Significant responscs in hindquarter and mesenteric blood fl.ow 
after DAGO were independent of systemic hemodynamic responses at the dose ofO.l nmol. The vascular 
resistance in the hindquarters significantly decreased after a small dose of DAGO while the larger doses 
dose-dependently increased mesenteric and renal vascular resistance. A crucial role of the sympathetic 
nervous system in the hemodynamic effects of DAGO was demonstrated: (1) by the profound activation 
of renal sympathetic nerve activity after injections of DAGO (I nmol/100 nl) into the preoptic nucleus, 
(2) by blockade of the pressor, tachycardic and regional hemodynamic effects of DAGO (I nmol) by the 
ganglion blocker ch1orisondamine (5 mgjkg i.v.). The results suggest that the pressor effect of DAGO in 
preoptic nucleus is due primarily to an increase in cardiac output. The differential changes in blood ftow 
in organs further suggest that the opioid p-receptors in the preoptic nucleus might be involved in the 
integration of peripheral blood ftow in the hypothalamus during affective behavior. 
Key words-o-Ala2-Me-Phe4-Gly-ols-enkephalin (DAGO), chlorisondamine, blood pressure, heart rate, 
cardiac output, regional blood ftow, sympathetic nerve activity. 
Opioid peptides and opiate receptors are present 
in hypothalamic nuclei and opioid peptide contain-
ing Connections have been demonstrated from the 
hypothalamus to other cardiovascular nuclei (para-
brachial nuclei, nucleus tractus solitarius) and to 
the preganglionic sympathetic nerve roots in the 
intermediolateral cell column of the spinal cord 
(Khachaturian, Lewis, Schafer and Watson, 1985; 
Mansour, Khatchaturian, Lewis, Akil and Watson, 
1988; Pasternak and Wood, 1986). Opioid peptides 
induce a complex pattern of cardiovascular changes, 
which has been attributed to multiple opiod recep-
tors: p- and h-receptors mediating the pressor and 
kappa-receptors mediating the depressor responses 
to centrally-administered opioids (Feuerstein, 1985; 
Feuerstein and Siren, 1987). Previous studies in this 
laboratory have shown that the selective p-opiate-
receptor agonist, o-Ala2-Me-Phe4-Gly-ol5-enkephalin 
(DAGO) (Handa, Lane, Lord, Morgan, Rance and 
Smith, 1981) increases blood pressure and causes a 
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biphasic heart rate response (tachycardia at small 
doses but bradycardia, followed by tachycardia, 
at large doses) upon injections into the ventricles of 
the brain or into the medial preoptic-anterior hypo-
thalamic area of the conscious rat (Pfeiffer, Feuerstein, 
Faden and Kopin, 1982; Pfeiffer, Feuerstein, Kopin 
and Faden, 1983a; Pfeiffer, Feuerstein, Zerbe, Faden 
and Kopin, 1983b). In tbe pentobarbital anesthetized 
rat, small (pmol) doses of DAGO, injected into the 
medial preoptic nucleus of hypothalamus, increased 
heart rate while larger doses produced hypotension 
and tachycardia (Faden and Feuerstein, 1983). Other 
investigators discribed pressor and tachycardic 
responses to DAGO, injected into the paraventricular 
nucleus in conscious rats (Kiritsy-Roy, Appel, 
Bobbitt and Van Loon, 1986). The cardiovascular 
effects of Stimulation of p-opioid receptors in the 
hypothalamic nuclei have been argued to be due to 
activation of the sympatho-adrenomedullary system, 
since concomitantly with their peak effect on blood 
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pressure and heart rate, centrally-injected selective 
Jt-agonists, like DAGO and dermorphin induce rises 
of catecholamines in plasma (Kiritsy-Roy et a/., 1986; 
Appel Kiritsy-Roy and Van Loon, 1986; Appel and 
Van Loon, 1986; Siren, Paakkari, Goldstein and 
Feuerstein, 1989). Moreover, the pressor and tachy-
cardic effects of DAGO were attenuated or even 
reversed in adrenal demedulated rats, treated with 
the sympathetic blocker bretyJium (Pfeiffer et a/., 
1982). The bradycardic and hypotensive response to 
centrally injected DAGO, on the other band, have 
been related to its strong respiratory depressant 
action and to an activation of vagal pathways (Faden 
and Feuerstein, 1983; Pfeiffer et al., 1983b; Hassen, 
Feuerstein and Faden, 1984). Though the effects of 
Jt-opioid agonists on blood pressure and heart rate 
are weil characterized, little is known about the 
hemodynamic mechanisms underlying these actions 
or their effects on discrete redistribution of blood 
flow in peripheral organs. Since the preoptic nucleus 
of the hypothalamus might be an important site 
for the integration of the hemodynamic component 
of the stress-evoked "defense reaction" (Yardley and 
Hilton, 1986) and the ~t-opioid agonists are known to 
induce potent systemic hemodynamic responses in 
this site, it was of interest to further explore the roJe 
of Jl·Opioid receptors in the preoptic nucleus, in 
the control of cardiac output and redistribution of 
blood flow to discrete organs. The role of the auto-
nomic nervous system in the systemic and regional 
hemodynamic responses to DAGO was also studied 
by treating the rats with the ganglion blocker 
chlorisondamine prior to administration of DAGO. 
In order to directly demoostrate sympathetic acti-
vation, the effect of DAGO on the activity of efferent 
renal sympathetic nerveswas examined in anesthetized 
rats and the changes in renal activity in nerves were 
correlated to the changes in blood flow in vivo, by 
simultaneously recording renal sympathetic nerve 
activity and renal blood flow. 
METHODS 
Male Sprague-Dawley rats (260-340 g) were used 
in all experiments. After the surgical Operations, 
the rats were housed individually in plastic cages 
(21 x 27 x 16 cm, H x L x H) with food and water 
ad libitum. 
lnjections into the brain 
The rats were anesthetized wtih an intramuscular 
injection of ketamine-acepromazine, 0.13 ml/100 g of 
a solution of ketamine (I 00 mg/ml) and acepromazine 
(I mgjml) and placed in a stereotaxic device (DKI, 
California). A stainless steel guide cannula was 
inserted through the skull and fixed with glue (East-
man 910 adhesive). Coordinates for the injections 
into the medial preoptic nucleus of the hypothalamus 
were measured from the bregma: AP = 0.2 mm and 
L = 0.6 mm. For intracerebroventricular injections, 
the coordinates from the bregma were: AP = 0.8 mm, 
L = 1.2 mm, V= 7.5 mm. On the day of the exper-
iment, injection of 0.9% (w/v) NaCJ (saline) or 
DAGO was made by means of a premeasured 30 g-
cannu1a, inserted into the preoptic nucleus (V = 
7.7 mm from dura Ievel) through the guide cannula. 
The injection cannula was then connected by a 
polyethylene tube to a Hamilton microliter syringe 
and a volume of I 00 nl or l~tl of the control or 
solution of drug was injected over a period of 30 sec. 
The proper position of the injection cannula was 
confirmed microscopically after the experiments, 
according to the brain atlas of König and Klippe! 
(1967). 
M easurement of cardiac output 
The effect of DAGO on cardiac output and total 
peripheral resistance was investigated according to 
the following protocol: the rats were anesthetized 
with ketamine-acepromazine and PE-50 tube inserted 
into the femoral arteries. These catheters were 
tunnelled beneath the skin of the back and exited at 
the back of the neck, as described above. Then, an 
incision was made at the midline of the neck from the 
cricoid to the clavicle and a PE-50 tubewas inserted 
into the right atrium, through the extemal jugular 
vein. Then, the left common carotid artery was 
exposed, Iigated and a thermistorprobe (MX2-780-33 
Model THMP f # 1.5, Teflon reusable, Columbus 
Instruments, Ohio) was advanced through the carotid 
into the ascending aorta (placement above the aortic 
valve was confirmed in each animal at the end of 
the experiment and by the shape of the dilution 
curve before the probe was finally sutured to the 
neck muscles). The jugular vein catheter and the 
thermistor probe was tunnelled under the skin to 
the back of the neck. All lines were secured by a soft 
spring wire, throughout the cage. Twenty-four hr 
after surgery, the arterial line was connected to a 
blood pressure transducer (Narco RPI500i) and the 
continuous recording of b1ood pressure (systolic, 
diastolic, mean) and heart rate was carried out by the 
Narcotrace 80 computerized dynograph. The cardiac 
output was measured by a thermodilution technique, 
as the thermistor was attached to the computerized 
Cardiomax II (CMx2-780-k with the microprobe 
option R, Columbus Instruments, Ohio). The dead-
space of the venous line was first flushed with 0.2 ml 
of saline at room temperature (22°C); after a brief 
period of stabilization (10 sec to assure normal core 
temperature), an additional injection of 0.05 ml 
normal saline (2rC) was rapidly made using a 1 ml 
syringe. Cardiac output was recorded in the follow-
ing way: a control period of 15 min included 2-~ 
measurements of cardiac output to test for consist-
ency and placement of the probe and also to get 
control values for mean arterial pressure and heart 
rate. The time on the automatic data collection 
system was started and data points were taken 
immediately before and 5, 10, 15, 30, 45, 60, 90 and 
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120 min after the injection of drug. Total peripheral 
resistance was calculated by dividing the mean 
arterial pressure by the cardiac output; values of 
cardiac output and total peripheral resistance were 
further indexed per unit of weight (kg). 
M easurement of blood flow with the directional pulsed 
Doppler technique 
Another set of rats was used to study the effect of 
DAGO on regional blood ftow and vascular resist-
ance by the directional pulsed Doppler technique. 
The Doppler method is preferred to the micro-
sphere or electromagnetic flow technique, because it 
allows continuous measurements of blood ftow and 
vascular resistance in the conscious, freely moving 
rat. The animals were anesthetized with ketamine-
acepromazine and miniaturized Doppler ftow probes 
(Valpey Fisher, Massachusetts) were implanted 
around the abdominal aorta, superior mesenteric 
artery and the left renal artery, according to the 
method described by Haywood, Shaffer, Fastenow, 
Fink and Brody (1981). Briefly, a midline laparotomy 
was made and 4 mm lengths of a Iower abdominal 
aorta, ~low the left renal artery, the superior 
mesentenc artery and the feft renal artery were 
carefully isolated, with the aid of a dissecting micro-
scope. Minaturized Doppler flow probes were then 
sutured around each vessel. The wire Ieads were 
tunnelled beneath the skin and exteriorized at the 
nape of the neck, where they were soldered to a 
connector plug, which was fixed to the skull of the 
animal with small screws and dental acrylic cement. 
The animals were allowed to recover for at least 
7 days from the surgery. Twenty-four hr before 
the experiment, the animal was anesthetized with 
halothane (2% in oxygen) and arterial and venous 
catheters (PE50) were introduced into the femoral 
vessels. The catheters were led beneath the skin to exit 
at the neck and secured in place with an adhesive 
coJlar. 
On the day of the experiment, the rat was 
connected to the flow-probe connectors and the 
connector line was suspended from the top of the 
home cage to allow freedom of movement during 
the experiment. Regional blood flow was measured 
with a directional pulsed Doppler flowmeter (Model 
# 545C-3, University of Iowa Bioengineering Facility, 
Iowa). The arterial line was attached to a pressure 
transducer (as above) and the blood pressure, heart 
rate and regional blood ftows were continuously 
recorded on the Narco dynograph. Vascular resist-
ance was calculated by dividing the mean arterial 
pressure by blood velocity (Doppler shift in kilo-
hertz). Changes in blood flow and vascular resistance 
are expressed as a percentage of control values. In 
som~ ~nimals, the vascular reactivity to exogenously 
~dmtmste~ed ca~echolamines was tested by an injec-
tton of epmephnne 0.3-1 Jlg/kg) and norepinephrine 
0.3-1 Jlg/kg), given intravenously, before the central 
injections. The responses to these reference sub-
stances werein accord with previously published data 
(Faber, Barron, Bonham, Lappe, Muirhead and 
Brody, 1984; Sirc~n, Lake and Feuerstein, 1988). 
Recording of activity in renal sympathetic nert•e in 
anesthetized rats 
To further support the evidence that stimulation of 
Jl·Opioid receptors in the preoptic nucleus acti-
vates the sympathetic nervous system, the effect of 
DAGO in renal sympathetic nerve activity and blood 
flow was studied in anesthetized rats. In these exper-
iments, the animals were first anesthetized with 
halothane (2% in oxygen) and arterial and venous 
catheters (PE50) were inserted into the femoral 
vessles. Thereafter, the anesthesia was continued with 
an intravenous infusion of chloralose ( 100 mg/kg) 
and the trachea cannulated. The animal was artifi-
cially respirated with oxygen during the experiment. 
From an incision in the Jeft flank, a branch of the 
renal nerve was traced to the renal artery, separated 
from the fat and connective tissue and placed on a 
bipolar platinum hook electrode (Cooner Wire Co., 
Chatsworth, California). A Doppler flow probe was 
placed around the renal artery, distal from electrode 
and the renal blood flow was continuously recorded. 
The tissue was protected by a pool of warm minerat 
oil. The nervesignalwas amplified ( x 10,000-50,000) 
and fittered (low 30, high 3000Hz) with a Grass P511 
Bandpass amplifier (Grass Instrument Co., Quincy, 
Massachusetts) and the amplified and filtered signal 
was cha~nelled to a Tektronix 5113 oscilloscope 
(Tektromx Inc., Beaverton, Oregon) for visual evalu-
ation, to an audio amplifierfsound speaker for audi-
tory evaluation and to a rectifying voltage integrator 
(Narco 730M). The rectified neurogram and inte-
grated nerve signal were displayed on the Narcotrace 
physiograph. The quality of the nerve signal and 
blood flow was assessed by examining the magnitude 
of change in recorded activity of the nerve, during 
baroreceptor Ioading and unloading, with an intra-
venous injection of norepinephrine ( 1 J.l. g/kg) and 
sodium nitroprusside (3 Jlg/kg). The efferent nature 
of the re~al nerve fibers was further verified by 
complete stlence of nerve activity, after injection of 
hexamethone (20 mg/kg, i.v.). At the end of the 
experiment, the renal nerve was cut and the zero 
activity was measured from the distal nerve stump. 
This remaining activity was substracted from the 
previously recorded activity of the nerve. 
Drugs used 
n-Ala2-Me-Phe4-Gly-ol 5-Enkephalin (OAGO) 
(Peninsula, Louisiana) was dissolved in saline and 
injected into the preoptic nucleus at the dose of 
0.1, 1 or 10 nmoljrat. The injection volume in the 
experiments on blood flow and nerve activity was 
I 00 ~1 and .in th.e cardiac output studies it was I lll. 
L-Epmephnne bttartrate and /-norepinephrine hydro-
chloride (Sigma, Missouri), sodium nitroprusside 
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(Roche) and chlorisondamine hydrochloride (Ciba-
Geigy) were dissolved in saline and injected intra-
venously in a volume of 25 JLl/100 g body weight. 
Statistical analysis of the data 
Data in the text and figures are represented as 
means ±SEM for the indicated number of rats. 
Analysis of variance with repeated measures 
(MANOV A, CSS complete Statistical System, Stat-
Soft, 1987) and one-way analysis at variance 
(ANOV A), followed by Student-Newman-Keul 
test, were used for statistical analysis of the data. 
A significant difference was accepted at P < 0.05. 
RFSULTS 
Effect of DAGO on blood pressure and heart rate 
(Figs 1 and 2) 
Injection of DAGO (I or 10 nmol) into the pre-
optic nucleus dose-dependently increased the blood 
pressure. The maximum rises of mean arterial pressure, 
after the I and 10 nmol doses, were + 14 ± 4 mmHg 
(P < 0.01) and +26 ± 4mmHg (P < 0.01), respect-
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Fig. I. Effect of DAGO, injected into the preoptic nucleus 
of the hypothalamus, on mean arterial pressure and heart 
rate in the conscious rat. Values represent means ±SEM. 
Asterisks denote statistical significance vs saline group by 
Student-Newman-Keul test; • P < 0.05. The time-response 
effect at both dose Ievels was significant when assessed by 
two-way MANOVA with repeated measures; the F and 
P-values for the mean arterial pressure were F = 4.78354, 
P = 0.00000 (l nmol vs saline) and F = 7.73935, P = 
0.00000 (10 nmol vs saline), F = 2.96753, P = 0.00458 
(I nmol vs 10 nmol). The corresponding values for the 
heart rate were F = 2.11526, P = 0.03653 ( 1 nmol vs saline), 
F = 8.34186, P = 0.00000 (10 nmol vs saline) and F = 
3.44125, P = 0.00151 (1 nmol vs 10 nmol). The number of 
animals in each group is given in parentheses. 
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Fig. 2. Effect of DAGO, injected into the preoptic nucleus, 
on systolic arterial pressure, pulse pressure and diastolic 
pressure in the conscious rat. Values represent means ± 
SEM. Asterisks denote statistical significance vs saline 
group by Student-Newman-Keul test; • P < 0.05. The 
time-response effect at both dose Ievels was significant when 
assessed by two-way MANOVA with repeated measures; 
the F and P -values for the systolic arterial pressure were 
F = 6.15946, P = 0.00000 (1 nmol vs saline) and F = 
6.29410, P = 0.00000 (lOnmol vs saline), F = 2.2159, 
P = 0.03096 (1 nmol vs I 0 nmol). The corresponding values 
for the pulse pressure were F = 2.35000, P = 0.02023 
(l nmol vs saline), F = 5.55830, P = 0.00000 (10 nmo1 vs 
saline) and F = 2.13208, P = 0.03798 ( 1 nmol vs 10 nmol); 
and for the diastolic pressure F = 3.03660, P = 0.00378 
(1 nmol vs saline, F = 3.47959, P = 0.00144 (10 nmol vs 
saline), the etfect at 1 nmol was not significant as com-
pared to the effect at 10 nmol (F = 1.81552, P = 0.08089). 
The number of animals in each group is given in parentheses. 
ively. The changes in systolic, diastolic and pulse 
pressure after the I nmol dose were + 19 ± 6 mmHg, 
+9 ± 5 mmHg and + 10 ± 3 mmHg (P < 0.05), 
respectively. The corresponding changes after the 
10 nmol dose were + 34 ± 8 mm Hg, + 16 ± 5 mmHg 
and + 17 ± 3 mmHg (P < 0.05), respectively. The 
pressor response to DAGO became apparent in 
3 min after the injection of the drug and reached a 
maximum 10 min after the injection, but the blood 
pressure remained elevated for more than an hour 
after the administration of DAGO. The smallest dose 
of 0.1 nrnol of DAGO had no significant effect on 
blood pressure. 
Hemodynamic effects of DAGO in rats 147 
The injection of DAGO into the preoptic nucleus 
induced a biphasic heart rate response: immediately 
after the 0.1 nmol dose (1-5 min), the heart rate 
initially decreased slightly (- 10 ± 4 bpm), followed 
by a significant tachycardic response ( +47 ± 13 bpm, 
P < 0.05) at 30 min after the injection. The 1 nmol 
dose decreased heart rate (- 39 ± 11 bpm, P < 0.05) 
only, while the 10 nmol dose produced bradycardia 
(- 68 ± 15 bpm, P < 0.05, at 10 nmol) about 30 min 
after injection of the drug and at 45--60 min tachy-
cardia ( + 74 ± 13 bpm, P < 0.05), which subsided in 
120min. Saline (lOOnl or 1 J.J.l) had no significant 
effect on blood pressure or heart rate. 
Intracerebroventricular injection of DAGO at the 
10 nmol dose induced a transient increase in blood 
pressure, with a maximum of + 15 ± 4 mm Hg 
(P < 0.05) 5 min after the injection (Table 1). The 
pressor response was succeeded by a decrease in 
blood pressure reaching a maximum (- 23 ± 5 mm 
Hg, P < 0.05) 30 min after intraventricular injection 
of DAGO. After intraventricular injection, DAGO 
I 0 nmol did not decrease heart rate but produced 
a tachycardic response which reached a maximum 
of + 74 ± 10 bpm (P < 0.05) at 20 min after the 
injection. 
Effect of DAGO on cardiac outpur and total peripheral 
resistance (Fig. 3) 
Doses of 1 nmol and I 0 nmol of DAGO 
produced a dose-re1ated increase in cardiac output. 
The maximum rises in cardiac output were + 41 ± 
17 ml/min/kg (P < 0.05) and + 98 ± 28 ml/min/kg 
(P < 0.01), respectively. The maximum effect after 
the 1 0 nmo1 dose was achieved 10 min after the 
injection, but the cardiac output remained signifi-
cantly elevated for 90 min after administration of 
DAGO. The increase in cardiac output after the 
1 nmol dose subsided in 60 min. The effect of 
DAGO on total peripheral resistance was not signifi-
cant, compared to the saline-control, though the total 
peripheral resistance slightly increased 5 min after 
injection of the 10 nmol dose. Saline, injected into the 
preoptic nucleus in a volume of 1 J.J.l, had no effect on 
these hemodynamic variables. 
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Fig. 3. Effect of DAGO, injected into the preoptic nucleus, 
on cardiac output and total peripheral resistance in the 
conscious rat. Values represent means ±SEM. Asterisks 
denote statistical significance vs saline group by Student-
Newman-Keul test: • P < 0.05. The time-response effect at 
both dose Jevels was significant when assessed by one-way 
MANOVA with repeated measures; F =4.47991, P = 
0.00140 (I nmol) and F = 4.66638, P = 0.00212 (10 nmol). 
The effect of saline was not significant (F = 1.44786, 
P = 0.20783). The nurober of animals in each group is given 
in parentheses. 
Effect of DAGO on regional blood fiow and vascular 
resistance (Fig. 4) 
Blood flow in hindquarters. The small dose 
(0.1 nmol) of DAGO, which had no effect on systemic 
blood pressure variables, significantly increased 
b1ood ftow in the hindquarters, due to a decrease in 
vascular resistance in the hindquarters. The larger 
doses also significantly increased blood flow to the 
hindquarter, but had no effect on regional vascular 
resistance. The blood ftow in the hindquarters was 
still significantly increased 30 min after the 1 nmol 
dose. 
Mesenteric blood flow. The blood ftow in the 
mesenteric artery was decreased even by the smallest 
Table I. Effect of DAGO on mean arterial pressure and heart rate in conscious rats after intracerebro-
ventricular (i.c.v.) administration. Values indicate actual values of mean arterial pressure (MAP) and heart 
rate (HR) after intraventricular injection of DAGO (10 nmol/10 #ll) or saline (10 lll) 
NP 30t2-{' 
Minutes after intraventricular injection 
Group Baseline 10 20 30 
Saline (i.c.t•.) 
MAP (mmHg) 131 ± 6 131 ± 7 130 ± 6 128 ±6 129 ± 6 
HR (bpm) 320 ± 21 345 ± 21 333 ± 22 347 ± 20 340 ± 21 
DAGO IOnmol (i.c.v.) 
MAP (mmHg) 130 ± 6 145 ± 9 140±8 122 ±4 108 ± 8 
HR (bpm) 390± 11 428 ± 18 443 ± 6* 464 ± 9• 461 ± 9• 
Values indicate mean ±SEM, N • 6, MAP = mean arterial pressure, HR = heart rate, bpm = beats per min. 
Asterisks indicate statistical difference between the two groups by Student-Newman-Keu1 test 
(* P < 0.05). The time-response effect, as compared to saline treated group, was significant when assessed 
by two-way MANOVA with repeated measures; the Fand P-values for MAP were F ar: 8.15396 and 
P = 0.00017 and for the heart rate F • 6.95822, P = 0.00041. 
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Fig. 4. Effect of DAGO, injected into the preoptic nucleus, on regional blood ftow and vascular resistance 
in the conscious rat. Values (means ±SEM) represent changes 3 and 30 min after injection of DAGO or 
saline. Asterisks denote statistical significance vs saline group by Student-Newman-Keul test; • P < 0.05, 
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dose of DAGO, the ]arger doses decreased mesenteric 
blood flow in a dose-related manner. The reduction 
in mesenteric blood flow was accompanied by an 
increase in vascular resistance. After the 1 nmol 
dose, the mesenteric vascular resistance was still 
significantly increased, 30 min after the injection. 
Renal blood flow. In the artery, DAGO (I and 
JO nmol) induced a gradual decrease in the blood 
flow and increase in the vascular resistance. The 
maximum decrease in blood flow became apparent 
30 min after the administration of DAGO and 
subsided in 120 min. Similarly, DAGO induced a 
long-lasting increase in vascular resistance with a 
maximum at 30 min, but the renal resistance 
remained high during the whole observation period 
of 120min. 
Microinjections of saline (100 nl) into the preoptic 
nucleus had no effect on the blood flow or vascular 
resistance in any of the blood vessels studied. 
Injluence of chlorisondamine 
The ganglion blocker chlorisondamine (5 mg/kg 
i.v.) significantly decreased mean arterial pressure 
and increased heart rate. The renal blood ftow was 
significantly less in chlorisondamine-treated rats, 
while in mesenteric and hindquarter vascular beds, 
the flow was maintained due to a decrease in vascular 
resistance (Table 2). 
Chlorisondamine totally blocked the pressor 
response to DAGO (1 nmol) in the preoptic nucleus 
(Fig. 5). The initial bradycardia produced by DAGO 
(I nmol) was not affected by chlorisondamine 
{23 ± 3 bpm in control vs - 16 ± 8 bpm in chlori-
sondamine treated group), while the late tachycardic 
responses to DAGO were significantly attenuated 
{ + I 08 ± 23 bpm in control vs + 40 ± 20 bpm in 
chlorisondamine, P < 0.05). The increase in hind-
quarter blood ftow by DAGO (1 nmol) in the pre-
optic nucleus was blocked by chlorisondamine, as 
Table 2. Resting Ievels of systcmic and regional hemodynamic 
variables before administration of DAGO in saline- or chlori-
sondamine (5 mg/kg i.v.)-treated rats 
Control Chlorisondamine 
MAP (mmHg) 117 ± 5 79±5 .. 
HR (bpm) 367 ± 21 310 ± 6• 
Blood jiow (k Hz) 
HQ 5.2 ± 0.4 6.1 ± 1.3 
R 8.4 ± 0.4 4.8 ± 0.9• 
M 4.4 ± 0.5 4.6 ± 0.4 
Resistance (mmHg jkHz) 
HQ 28 ± 4 15 ± J• 
R 20±8 21 ± 5 
M 30±4 18± J· 
Values indicate mean ±SEM, N = 7, MAP = mcan arterial press-
ure, HR = heart rate, bpm = beats per minute. HQ = hind-
quarter, R ... renal, M ... mesenteric. Asterisks indicate statistical 
difference between the two groups by Student-Newman-Keul 
test (•P < 0.05, .. P < 0.01). 
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was also the vasoconstrictor responses in renal and 
mesenteric arteries (Fig. 5). 
E.ffect of DAGO on sympathetic nerve activity in 
anesthetized rats (Fig. 6) 
In a separate group of artificially ventilated rats, 
anesthetized with chloralose, injection of DAGO 
(I nmol/100 nl) into preoptic nucleus induced a 
biphasic change in the renal nerve activity. Initially, 
the activity in the renal nerve tended to decrease 
during the first 5 min after injection of drug. This 
initial sympathoinhibition was then replaced by an 
increase in activity 10 min after injection of DAGO. 
However, no significant changes were observed in 
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renal blood flow or systemic pressure, whereas the 
heart rate increased concomitantly with the increase 
in activity in the renal nerve. 
DISCUSSION 
Injections of DAGO (1 or 10 nmoljrat), a selective 
,u-opiate receptor agonist (Handa et al., 1981 ), into 
the preoptic nucleus of the hypothatamus elicited 
dose-related rises of blood pressure, accompanied by 
a biphasic heart rate response in the conscious rat. 
These results are in agreement with the previous 
findings that injections of selective 14-agonists, such 
as DAGO and dermorphin, into the preoptic nucleus 
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Fig. 5. Inftuence of chlorisondamine on the DAGO-induced hemodynamic responses in the conscious 
rat. Chlorisondamine was injected intravenously 20 min before injection of DAGO (1 nmol) into the 
preoptic nucleus. The values represent means ±SEM. Asterisks denote statistical significance between the 
two groups by Student-Newman-Keul lest; •p < 0.05, ••p < O.Ol. MAP = mean arterial pressure, 
HQBF == hindquarter blood ftow, HQR = hindquarter resistance, MBF = mesenteric blood ftow, 
MR = mesenteric resistance, RBF ==renal blood ftow, RR =renal resistance. 
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or into the anterior hypothalamic nucleus, as weil as 
paraventricular hypothalamic nucleus, increased 
blood pressure and, depending on the dose, caused 
tachycardia or bradycardia in rodents (Diz, Vitale 
and Jacobowitz, 1984; Pfeiffer et al., 1982, 1983a, b; 
Feuerstein, Zerbe and Faden, 1983; Kiritsy-Roy 
et al., 1986), whereas injections of these JJ·Opioids 
into the dorsomedial or posterior hypothalamus bad 
no effect (Diz et al., 1984). In anesthetized rats, 
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Fig. 6. Effect of DAGO, injected into the preoptic nucleus, 
on activity in renal sympathetic nerves activity, mean 
arterial pressure, hcart rate, renal blood ftow and vascular 
resistance in the chloralose-anesthetized rat. Values (means 
± SEM) represent changes after injection of DAGO. 
Asterisks denote statistical significance from baseline by 
Student-Newman-Keul test; •p < 0.05. 
comparable doses of DAGO, injected into the 
anterior hypothalamic/preoptic region, decreased the 
blood pressure and induced tachycardia (Faden and 
Feuerstein, 1983). Pressor and tachycardic responses 
in the conscious anima1s, but cardiovascular 
depression in anesthetized animals, are also observed 
after systemic or central administration of morphine 
or enkephalins (Bolme, Fuxe, Agnati, Bradley and 
Smythies, 1 978; Schaz, Stock, Simon, Schlör, U nger, 
Rockhold and Ganten, 1980; Laubie and Schmitt, 
1981). 
Since the volume of injection, used in the present 
experiment (I J.L 1) was fairly ]arge, the etfects 
described in the present report might have been due 
to activation of other neighboring nuclei, in addition 
to the preoptic nucleus. However, multiple reasons 
suggested that the hemodynamic changes, elicited by 
DAGO, were due to an action restricted within the 
region of the preoptic nucleus. Firstly, studies using 
tritiated enkephalin have shown that around 90% 
of the injected radioactivity, after 1 J.L I injections 
of o-ala2-o-leu-enkephalin (DADL) into preoptic 
nucleus was confined to an area with a radius of 1 mm 
from the site of injection (Feuerstein et a/., 1982). 
Moreover, injections of a 1 JJI volume of DADL 
produced increases in blood pressure and heart rate 
in the preoptic nucleus, whereas injections into the 
periventricular preoptic nucleus (with an AP coordi-
nate I mm anterior from the coordinate of the preoptic 
nucleus), resulted in hypotension and bradycardia 
(Feuerstein and Faden, 1982). In the present study, 
injections of DAGO at all doses produced identical 
responses when injected into the preoptic nucleus 
regardless of the injection volume, whereas intra-
cerebroventricular injections of the 10 nmol dose 
of DAGO produced a qualitatively different heart 
rate response (tachycardia only) and a transient and 
moderate pressor response, which was succeeded by 
a hypotensive effect 20 min after the intraventricular 
injection, while the same dose of DAGO in the 
preoptic nucleus produced profound pressor effect 
and a bradycardic-tachycardic response. Therefore, 
it seems likely that activation of neurons in the 
preoptic nucleus, rather than wide-spread Stimulation 
of hypothalamic nuclei, accounted for the effects of 
DAGO after injection into the preoptic nucleus. 
The tachycardic and pressor responses to centrally-
injected DAGO are likely to be due to an activation 
of the sympathetic nervaus system, since these 
responses were effectively blocked by the ganglion 
blocker, chlorisondamine. Earlier studies have shown 
that, concomitantly with its peak cardiovascular 
effects, the ~ -opioid agonists DAGO and dermorphin 
induced rises of epinephrine and norepinephrine in 
plasma in the conscious rat (Kiritsy-Roy et al., 1986; 
Appel et al., 1986; Siren et al., 1989). Moreover, these 
cardiovascular changes were partly attenuated in 
adrenal demedulated animals and even reversed when 
these rats were further treated with bretylium (Pfeiffer 
et al., 1983b). Tachycardia seems also to be the 
Hemodynamic effects of DAGO in rats 151 
primary effect of DAGO in anesthetized rats, since 
extremely small doses ofDAGO, which have no effect 
on blood pressure, cause acceleration of the heart 
(Faden and Feuerstein, 1983), whereas the hypo-
tensive and bradycardic effects, seen after large doses, 
are in part due to the potent respiratory depressant 
action of this agent (Pfeiffer et al., 1982; Hassen et al., 
1984), though a vagal component may also contrib-
ute (Pfeiffer et al., 1983b; Laubie and Schmitt, 1981 ). 
In the present study, DAGO injected into the 
preoptic nucleus increased cardiac output. The rise in 
cardiac output induced by DAGO became apparent, 
concomitantly with the peak presser response, while 
it bad no significant effect on total peripheral 
resistance. Thus, the hypertensive effect of DAGO 
seems to be mediated by its action on the cardiac 
output. Since the increase in cardiac index was 
accompanied by bradycardia, a positive inotropic 
effect and/or increased venous retum to the heart 
may underlie the improvement in cardiac index, 
produced by DAGO. The Iack of effect of DAGO on 
peripheral resistance, on the other band, may be due 
to its opposite action on hindquarter vs renal and 
mesenteric blood flow and vascu]ar resistance. In the 
hindquarter, DAGO dose-dependently increased the 
blood flow and vascular resistance, but in the 
mesenteric and renal vasculature it reduced the blood 
flow and raised the vascular resistance in a dose-
related manner. 
The pattern of changes in blood flow in ergans 
(an increase in hindquarters but decreases in 
mesenteric and renal vascular beds), induced by 
DAGO, suggests an activation of the sympatho-
adrenomedullary system. Indeed, these effects were 
attenuated by the ganglion blocker chlorisondamine, 
indicating that these effects were mediated by acti-
vation of sympathetic nerves and/or adrenal medulla. 
These findings are supported by the earlier sturlies 
(Pfeiffer et al., 1983b) that intrahypothalamic injec-
tions of DAGO (7.5 nmol) increased epinephrine and 
norepinephrine in plasma by 17 and 5 fold, respect-
ively. Moreover, the present study provided direct 
evidence for activation of sympathetic nerves; activity 
in the renal nerve was increased over 150o/o by 
injection of DAGO into the preoptic nucleus, even at 
doses which did not significantly alter blood pressure 
or renal blood flow. 
However, the increase in activity in the renal 
nerve was preceded by a brief initia] decrease. This 
inhibition/stimulation pattern of changes in activity 
agree with the typical heart rate response to 1-l -opioid 
agonists; bradycardia followed by tachycardia 
(Pfeiffer et a/., l983a, b; Sin~n et a/., 1989). In a 
recent study, another 1-'·opioid agonist, morphine, 
was shown to induce a transient decrease in activity 
in the renal nerve after intravenous administration 
in chloralose-anesthetized rats (DeHe, Thoren, 
Skarphedinsson, Hoffman, Carlsson and Ricksten, 
1990). The decrease in activity was not only com-
pletely abolished but replaced by a profound increase 
in activity in vagotomized rats and was therefore 
suggested to be mediated by a reflex activation of 
vagal afferents (Delle et al., 1990), which was pre-
viously shown to underlie the sympathoinhibitory 
and hypotensive effects of the enkephalin-analog, 
o-ala2-met2-enkephalinamide (DAME) after injec-
tions into the right atrium (Willette, Krieger and 
Sapru, 1982). The bradycardic effect of centrally-
administered DAGO was also reduced by atropine 
methy1 nitrate in an earlier study (Pfeiffer et al., 
l983b), as weH as the cardiorespiratory depressant 
effect of JJ -opioid agonists (Pfeiffer et al., 1982; 
Hassen et al., 1984). Thus, the 1-'-opioid agonists seem 
to produce activation of both sympathetic and vagal 
outflow. 
The biphasic pattern of cardiovascular responses 
to DAGO and other JJ·Opioid agonists might also 
concur with the hypothesis that JJ-opioid effects are 
mediated by two subclasses of opioid receptors: 
1-' 1-receptors mediating respiratory stimulatory and 
analgesic responses and JJ2-receptors mediating 
inhibitory and depressant responses (Pasternak 
and Wood, 1986; Paakkari, Paakkari, Siren and 
Feuerstein, 1990). A recent study from this labora-
tory (Paakkari et a/., 1990) implied that the 1-'1• 
receptors mediate respiratory stimulation, while 
activation of 1-'2-receptors was responsible for the 
respiratory depressant effect of the J.L-agonist der-
morphin. lt would be tempting to speculate that 
stimulation of multiple subclasses of JJ·Opioid recep-
tors could also explain the biphasic nature of the 
cardiovascular responses to DAGO. 
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